Hiding in plain sight – CRIO eSource is the biggest opportunity for sponsors. While the clinical research industry has automated many processes, there is one area that is still mostly paper-bound. This is the source of one of the greatest inefficiencies in research today. Automating this one process could drive 20% cost savings in a...
The FDA routinely audits clinical research sites, and some of those sites happened to use CRIO eSource on the studies in question. With our broad reach and history as the leading site-adopted eSource solution, we have now established a database of audit results that prove what we’ve known intuitively: CRIO eSource reduces audit risks for...
BOSTON, MA – November 3, 2022 – CRIO, the industry’s leading eSource provider, announces the appointment of Dr. Margaretta Nyilas to its Board of Directors, effective immediately. Dr. Nyilas is a biopharmaceutical executive with over twenty years of diverse global industry experience, formerly at Otsuka Pharmaceuticals, Bristol Myers Squibb and Click Therapeutics. She has a...
Bala Nair is the Enterprise Architect at CRIO. With over 20 years of experience in the technology industry, Bala has shaped several cutting-edge engineering developments, from AOL’s Instant Messenger, to building software that delivered over 50% of video on demand content to U.S. households. At CRIO, Bala partners with other strategic owners to manage CRIO’s...
Bridging the gap eSource is the bridge between the protocol and the eCRF fields. To understand why, we need to understand what each does. The protocol describes the purpose of the study, the core hypotheses, the endpoints that are to be collected, and the resulting procedures to be performed to support those endpoints. The eCRF...